1. Home
  2. IMCR vs LKFN Comparison

IMCR vs LKFN Comparison

Compare IMCR & LKFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMCR
  • LKFN
  • Stock Information
  • Founded
  • IMCR 2008
  • LKFN 1872
  • Country
  • IMCR United Kingdom
  • LKFN United States
  • Employees
  • IMCR N/A
  • LKFN N/A
  • Industry
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • LKFN Major Banks
  • Sector
  • IMCR Health Care
  • LKFN Finance
  • Exchange
  • IMCR Nasdaq
  • LKFN Nasdaq
  • Market Cap
  • IMCR 1.7B
  • LKFN 1.7B
  • IPO Year
  • IMCR 2021
  • LKFN 1997
  • Fundamental
  • Price
  • IMCR $33.50
  • LKFN $58.67
  • Analyst Decision
  • IMCR Buy
  • LKFN Buy
  • Analyst Count
  • IMCR 9
  • LKFN 2
  • Target Price
  • IMCR $62.38
  • LKFN $68.00
  • AVG Volume (30 Days)
  • IMCR 350.0K
  • LKFN 96.6K
  • Earning Date
  • IMCR 11-06-2025
  • LKFN 10-27-2025
  • Dividend Yield
  • IMCR N/A
  • LKFN 3.23%
  • EPS Growth
  • IMCR N/A
  • LKFN N/A
  • EPS
  • IMCR N/A
  • LKFN 3.79
  • Revenue
  • IMCR $356,145,000.00
  • LKFN $247,271,000.00
  • Revenue This Year
  • IMCR $29.99
  • LKFN $16.89
  • Revenue Next Year
  • IMCR $8.85
  • LKFN $4.98
  • P/E Ratio
  • IMCR N/A
  • LKFN $15.48
  • Revenue Growth
  • IMCR 26.78
  • LKFN 2.43
  • 52 Week Low
  • IMCR $23.15
  • LKFN $50.00
  • 52 Week High
  • IMCR $39.33
  • LKFN $78.61
  • Technical
  • Relative Strength Index (RSI)
  • IMCR 49.73
  • LKFN 37.25
  • Support Level
  • IMCR $31.36
  • LKFN $58.08
  • Resistance Level
  • IMCR $34.18
  • LKFN $62.02
  • Average True Range (ATR)
  • IMCR 1.38
  • LKFN 1.96
  • MACD
  • IMCR -0.00
  • LKFN -0.13
  • Stochastic Oscillator
  • IMCR 60.51
  • LKFN 9.80

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

About LKFN Lakeland Financial Corporation

Lakeland Financial Corp is a bank holding company. It provides commercial, retail, wealth advisory, and investment management services. It offers a broad line of products and services throughout its Northern and Central Indiana markets. The company provides commercial and consumer banking services, as well as trust and wealth management, brokerage, and treasury management commercial services. It serves a wide variety of industries including, among others, commercial real estate, manufacturing, agriculture, construction, retail, wholesale, finance and insurance, accommodation and food services, and healthcare.

Share on Social Networks: